Searched for
COVAXIN EFFICACY
Bharat Biotech says its Covaxin demonstrated ‘excellent safety records’Bharat Biotech has emphasized the safety of its Covaxin Covid vaccine, stating that it has shown excellent safety records with no vaccine-a...- No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension"For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety...
- Experts allay Covaxin concerns, effectiveness against Delta-driven Covid surge at 50% not badEfficacy is the degree to which a vaccine prevents disease, and possibly also transmission, under ideal and controlled conditions, while ef...
- Emergency Use Listing nod to Covaxin expands availability of Covid vaccines: WHO officialCovaxin was also reviewed on October 5 by WHO's Strategic Advisory Group of Experts on Immunization (SAGE), which formulates vaccine specif...
- Bharat Biotech claims 77.8% efficacy of Covaxin in phase-3 trialsAnnouncing the much awaited safety and efficacy data from phase-3 clinical trials of Covaxin, the IMCR director Prof Balram Bhargava said C...
- Covaxin phase 3 full trial data to be made public in July: Bharat BiotechThe indigenous whole virion inactivated SARS-Cov-2 virus vaccine company has also said that Covaxin will even undergo the phase 4 trials to...
- Government steps in to expedite WHO approval for CovaxinToI has learnt that foreign secretary Harsh Shringla will hold a meeting with Bharat Biotech, the manufacturer of Covaxin, on Monday to exp...
- Covaxin can neutralise double mutant variantPhase 3 clinical trials of Covaxin by Bharat Biotech International Ltd (BBIL) and ICMR have demonstrated 100% efficacy against severe Covid...
- Covaxin shows 100% efficacy against severe Covid-19, works well on variants“The tireless efforts of our scientists at ICMR and BBIL have resulted in a truly effective international vaccine of the highest standards ...
- Need to change Covaxin composition not felt yet due to vaccine's good efficacy against mutant variants: GovernmentProviding details of the efficacy rate of Covaxin and Covishield vaccines against each of the mutations, he said there was no significant d...
- Opposition did politics over COVID vaccine: BJP"I want to ask do you not trust scientists and doctors of your country? Over 40 countries have placed order for Covaxin. But in India, we h...
- Covaxin efficacy data has no effect on opposition statesA day after Hyderabad-based Bharat Biotech reported its interim data, the three states on Thursday said they would wait for a formal approv...
- Your coronavirus vaccine guide: Covishield vs CovaxinOxford-AstraZeneca-made Covishield is based on the viral vector platform. The vaccine is made by genetically engineering adenovirus that no...
- India's coronavirus vaccine, COVAXIN, likely effective against new British variant: StudyA study conducted by Indian Council of Medical Research (ICMR) on Covaxin showed a comparable neutralization activity of the vaccinated ind...
- Covaxin a hard sell in two of India’s largest hospitalsVaccine hesitancy has hit two of India’s largest state-run hospitals — JJ Hospital in Mumbai and the All-India Institute of Medical Science...
- India's Bharat Biotech aims to make 700 mln doses of COVID-19 vaccine in 2021The vaccine candidate, COVAXIN, received emergency use approval from India's drugs regulator on Sunday, a move that faced questions from in...
- Covishield and Covaxin: All you need to know about the DCGI-approved vaccinesET rounds up facts and some questions on Covishield and Covaxin, approved by DCGI on Sunday
- Bharat Biotech seeks DCGI nod for Covaxin use“After Pfizer and Serum Institute of India, Bharat Biotech has also applied to the drug regulator for market authorisation approval now,” s...
- After Haryana's Anil Vij tests positive, Bharat Biotech says COVAXIN efficacious, safe"COVAXIN clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days after the s...
- Phase 3 trial of Covaxin to begin in Haryana on Nov 20, Anil Vij offers to be first volunteerBharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being condu...
Load More
